Clincosm LogoSign in Get a demo

Gastroesophageal Reflux Disease

Showing 26 - 50 of 241
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Gastroesophageal Reflux Disease, Obesity Trial in Nashville (Dietary Carbohydrate)

Active, not recruiting
  • Gastroesophageal Reflux Disease
  • Obesity
  • Dietary Carbohydrate
  • Nashville, Tennessee
    Tennessee Valley Healthcare System Nashville Campus, Nashville,
Jan 27, 2022

Transoral Incisionless Fundoplication Database Repository (TIF)

Recruiting
  • Gastroesophageal Reflux Disease
  • no intervention, database study
  • Indianapolis, Indiana
    Indiana University Hospital
Jan 23, 2022

Survey Study on Barrett's Esophagus Screening

Recruiting
  • Gastroesophageal Reflux Disease
  • +2 more
  • Primary Care Provider Survey
  • +2 more
  • Aurora, Colorado
  • +6 more
Jan 20, 2022

Morbid Obesity, Hiatal Hernia, Gastroesophageal Reflux Disease Trial in Taipei (Laparoscopic sleeve gastrectomy + Hiatal hernia

Recruiting
  • Morbid Obesity
  • +3 more
  • Laparoscopic sleeve gastrectomy + Hiatal hernia repair
  • Laparoscopic sleeve gastrectomy alone
  • Taipei, Taiwan
    National Taiwan University Hospital
Jan 19, 2022

Gastroesophageal Reflux Disease, Critically Ill Trial in Lucknow

Recruiting
  • Gastroesophageal Reflux Disease
  • Critically Ill
    • Lucknow, UP, India
      Department of Critical Care Medicine, Sanjay Gandhi Postgraduate
    Jan 14, 2022

    Gastroesophageal Reflux Disease, Hiatal Hernia Trial in United States (TIF Transoral Fundoplication, Sham procedure)

    Completed
    Has Results
    • Gastroesophageal Reflux Disease
    • Hiatal Hernia
    • TIF Transoral Fundoplication
    • Sham placebo procedure
    • Los Angeles, California
    • +8 more
    Dec 1, 2021

    Gastroesophageal Reflux Disease Trial in Seoul (Atovaquone / Proguanil 250/100 mg, Tegoprazan 50 mg, Esomeprazole 40 mg)

    Completed
    • Gastroesophageal Reflux Disease
    • Atovaquone / Proguanil 250/100 mg
    • +3 more
    • Seoul, Korea, Republic of
      Seoul National University Hospital, Clinical Trial Center
    Sep 23, 2021

    Gastroesophageal Reflux Disease Trial in Spain (ARMA (antireflux ablation of the cardiac mucosa), upper digestive endoscopy)

    Recruiting
    • Gastroesophageal Reflux Disease
    • ARMA (antireflux ablation of the cardiac mucosa)
    • upper digestive endoscopy
    • Avilés, Spain
    • +9 more
    Sep 7, 2021

    Barrett's Esophagus, Gastroesophageal Reflux Disease Trial in Dallas (Cessation of Acid Suppressing Medications)

    Enrolling by invitation
    • Barrett's Esophagus
    • Gastroesophageal Reflux Disease
    • Cessation of Acid Suppressing Medications
    • Dallas, Texas
      Dallas VA Medical Center
    Aug 16, 2021

    Gastroesophageal Reflux Disease, Obesity Trial (Roux-en-Y-Gastric bypass, Sleeve gastrectomy, SG)

    Not yet recruiting
    • Gastroesophageal Reflux Disease
    • Obesity
    • Roux-en-Y-Gastric bypass, Sleeve gastrectomy
    • SG
    • (no location specified)
    Aug 16, 2021

    Gastroesophageal Reflux Disease Trial in Seoul (AD-214 10/600mg, Rabeprazole 10mg)

    Completed
    • Gastroesophageal Reflux Disease
    • AD-214 10/600mg
    • Rabeprazole 10mg
    • Seoul, Korea, Republic of
      Seoul National University Hospital
    Jul 20, 2021

    Gastroesophageal Reflux Disease Trial in Seoul (AD-214-02, Rabeprazole)

    Completed
    • Gastroesophageal Reflux Disease
    • Seoul, Korea, Republic of
      Seoul National University Hospital
    Jul 20, 2021

    Gastroesophageal Reflux Disease Trial in Seoul (Rabeprazole Sodium 10mg, Rabeprazole Sodium 20mg)

    Recruiting
    • Gastroesophageal Reflux Disease
    • Rabeprazole Sodium 10mg
    • Rabeprazole Sodium 20mg
    • Seoul, Daehak-ro Jongno-gu, Korea, Republic of
      Seoul National University Hospital
    Jun 25, 2021

    Gastroesophageal Reflux Disease Trial in Canada, United States (arbaclofen placarbil-Cohort 1, Placebo-Cohort 5, arbaclofen

    Completed
    • Gastroesophageal Reflux Disease
    • arbaclofen placarbil-Cohort 1
    • +5 more
    • Huntsville, Alabama
    • +63 more
    Feb 17, 2021

    Weight, Gut Microbiome, and Expression of GPR41 and GPR43

    Recruiting
    • Gastroesophageal Reflux Disease
    • Obesity
    • Colonoscopy
    • Weight and diet questionnaire
    • Aurora, Colorado
      University of Colorado Hospital
    Feb 17, 2021

    Gastroesophageal Reflux Disease Trial in Italy, Netherlands, United States (Torax Medical, Inc. LINX Reflux Management System)

    Completed
    Has Results
    • Gastroesophageal Reflux Disease
    • Torax Medical, Inc. LINX Reflux Management System
    • Los Angeles, California
    • +4 more
    Jan 28, 2021

    Gastroesophageal Reflux Disease Trial (Esomeprazole Magnesium Enteric-coated Tablets, Lifestyle adjustment)

    Not yet recruiting
    • Gastroesophageal Reflux Disease
    • Esomeprazole Magnesium Enteric-coated Tablets
    • Lifestyle adjustment
    • (no location specified)
    Jan 4, 2021

    Barrett Esophagus, Dysplasia, Esophageal Adenocarcinoma Trial in Portland (Cytology Specimen Collection Procedure, Laboratory

    Completed
    • Barrett Esophagus
    • +5 more
    • Cytology Specimen Collection Procedure
    • +3 more
    • Portland, Oregon
      OHSU Knight Cancer Institute
    Nov 23, 2020

    Gastroesophageal Reflux Disease and Dental Erosion

    Completed
    • Gastroesophageal Reflux Disease
    • Tooth Wear
      • Istanbul, Turkey
        Fatma Aytac Bal
      Oct 19, 2020

      Gastroesophageal Reflux Disease Trial in Columbus (Study Arm - acid suppression plus feeding bundle, Conventional arm - acid

      Completed
      Has Results
      • Gastroesophageal Reflux Disease
      • Study Arm - acid suppression plus feeding bundle
      • Conventional arm - acid suppression only
      • Columbus, Ohio
        The Research Institute at Nationwide Children's Hospital
      Jul 24, 2020

      Dexlansoprazole Modified Release in Gastroesophageal Reflux

      Withdrawn
      • Gastroesophageal Reflux Disease
        • (no location specified)
        Apr 13, 2020

        Esophagitis, Reflux Esophagitis, Gastroesophageal Reflux Disease Trial in Dallas (Cessation of Acid Suppressing Medications)

        Completed
        • Esophagitis
        • +2 more
        • Cessation of Acid Suppressing Medications
        • Dallas, Texas
          Dallas VA Medical Center
        Feb 4, 2020

        Hiatal Hernia, Gastroesophageal Reflux Disease Trial (Laparoscopic hiatal hernia repair with ProGrip™ mesh, Laparoscopic primary

        Completed
        • Hiatal Hernia
        • Gastroesophageal Reflux Disease
        • Laparoscopic hiatal hernia repair with ProGrip™ mesh
        • Laparoscopic primary posterior crural repair
        • (no location specified)
        Nov 5, 2019

        Coronary Artery Disease, Gastroesophageal Reflux Disease Trial in Beijing (Indobufen and aspirin mimetic, Aspirin and indobufen

        Unknown status
        • Coronary Artery Disease
        • Gastroesophageal Reflux Disease
        • Indobufen and aspirin mimetic
        • Aspirin and indobufen mimetic
        • Beijing, China
          Beijing Anzhen Hospital, Capital Medical University
        Oct 14, 2019

        Gastroesophageal Reflux Disease Trial in United States (IW-3718, Matching Placebo, PPI)

        Completed
        Has Results
        • Gastroesophageal Reflux Disease
        • Dothan, Alabama
        • +61 more
        Oct 14, 2019